Literature DB >> 24722905

Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates.

Madhu S Malo1, Omeed Moaven1, Nur Muhammad1, Brishti Biswas1, Sayeda N Alam1, Konstantinos P Economopoulos1, Sarah Shireen Gul1, Sulaiman R Hamarneh1, Nondita S Malo1, Abeba Teshager1, Mussa M Rafat Mohamed1, Qingsong Tao1, Sonoko Narisawa2, José Luis Millán2, Elizabeth L Hohmann3, H Shaw Warren3, Simon C Robson4, Richard A Hodin5.   

Abstract

The intestinal microbiota plays a pivotal role in maintaining human health and well-being. Previously, we have shown that mice deficient in the brush-border enzyme intestinal alkaline phosphatase (IAP) suffer from dysbiosis and that oral IAP supplementation normalizes the gut flora. Here we aimed to decipher the molecular mechanism by which IAP promotes bacterial growth. We used an isolated mouse intestinal loop model to directly examine the effect of exogenous IAP on the growth of specific intestinal bacterial species. We studied the effects of various IAP targets on the growth of stool aerobic and anaerobic bacteria as well as on a few specific gut organisms. We determined the effects of ATP and other nucleotides on bacterial growth. Furthermore, we examined the effects of IAP on reversing the inhibitory effects of nucleotides on bacterial growth. We have confirmed that local IAP bioactivity creates a luminal environment that promotes the growth of a wide range of commensal organisms. IAP promotes the growth of stool aerobic and anaerobic bacteria and appears to exert its growth promoting effects by inactivating (dephosphorylating) luminal ATP and other luminal nucleotide triphosphates. We observed that compared with wild-type mice, IAP-knockout mice have more ATP in their luminal contents, and exogenous IAP can reverse the ATP-mediated inhibition of bacterial growth in the isolated intestinal loop. In conclusion, IAP appears to promote the growth of intestinal commensal bacteria by inhibiting the concentration of luminal nucleotide triphosphates.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  CpG DNA; dysbiosis; flagellin; gut flora; intestinal loop model; lipopolysaccharides; microbiotal homeostasis

Mesh:

Substances:

Year:  2014        PMID: 24722905      PMCID: PMC4024727          DOI: 10.1152/ajpgi.00357.2013

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  64 in total

Review 1.  Probiotics, prebiotics, and synbiotics--approaching a definition.

Authors:  J Schrezenmeir; M de Vrese
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

Review 2.  Commensal host-bacterial relationships in the gut.

Authors:  L V Hooper; J I Gordon
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

3.  Dysbiosis as a prerequisite for IBD.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

Review 4.  Composition and function of the human-associated microbiota.

Authors:  Elisabeth M Bik
Journal:  Nutr Rev       Date:  2009-11       Impact factor: 7.110

5.  Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.

Authors:  Arnoldo J Riquelme; Mario A Calvo; Ana M Guzmán; María S Depix; Patricia García; Carlos Pérez; Marco Arrese; Jaime A Labarca
Journal:  J Clin Gastroenterol       Date:  2003-01       Impact factor: 3.062

6.  Intermediates in the hydrolysis of ATP by human alkaline phosphatase.

Authors:  D W Moss; A K Walli
Journal:  Biochim Biophys Acta       Date:  1969-11-04

7.  Bacteriuria testing by the ATP method as an integral part in the diagnosis and therapy of urinary tract infection (UTI).

Authors:  A Lundin; H Hallander; A Kallner; U K Lundin; E Osterberg
Journal:  J Biolumin Chemilumin       Date:  1989-07

8.  Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

Authors:  C Prantera; M L Scribano; G Falasco; A Andreoli; C Luzi
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 9.  The causes of intestinal dysbiosis: a review.

Authors:  Jason A Hawrelak; Stephen P Myers
Journal:  Altern Med Rev       Date:  2004-06

10.  Accelerated fat absorption in intestinal alkaline phosphatase knockout mice.

Authors:  Sonoko Narisawa; Lei Huang; Arata Iwasaki; Hideaki Hasegawa; David H Alpers; José Luis Millán
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more
  33 in total

1.  Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase.

Authors:  K P Economopoulos; N L Ward; C D Phillips; A Teshager; P Patel; M M Mohamed; S Hakimian; S B Cox; R Ahmed; O Moaven; K Kaliannan; S N Alam; J F Haller; A M Goldstein; A K Bhan; M S Malo; R A Hodin
Journal:  Diabetes Obes Metab       Date:  2016-03-22       Impact factor: 6.577

2.  Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase.

Authors:  Gloria Komazin; Michael Maybin; Ronald W Woodard; Thomas Scior; Dominik Schwudke; Ursula Schombel; Nicolas Gisch; Uwe Mamat; Timothy C Meredith
Journal:  J Biol Chem       Date:  2019-11-08       Impact factor: 5.157

3.  Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels.

Authors:  Wei Liu; Dong Hu; Haizhong Huo; Weifeng Zhang; Fatemeh Adiliaghdam; Sarah Morrison; Juan M Ramirez; Sarah S Gul; Sulaiman R Hamarneh; Richard A Hodin
Journal:  J Am Coll Surg       Date:  2015-12-18       Impact factor: 6.113

Review 4.  Intestinal alkaline phosphatase: a summary of its role in clinical disease.

Authors:  Jason Fawley; David M Gourlay
Journal:  J Surg Res       Date:  2015-12-17       Impact factor: 2.192

5.  Intestinal alkaline phosphatase deficiency leads to lipopolysaccharide desensitization and faster weight gain.

Authors:  Ye Yang; José Luis Millán; Joan Mecsas; Karen Guillemin
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

Review 6.  Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity.

Authors:  Mehrbod Estaki; Daniella DeCoffe; Deanna L Gibson
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

7.  Monitoring protein conformational changes using fluorescent nanoantennas.

Authors:  Scott G Harroun; Dominic Lauzon; Maximilian C C J C Ebert; Arnaud Desrosiers; Xiaomeng Wang; Alexis Vallée-Bélisle
Journal:  Nat Methods       Date:  2021-12-30       Impact factor: 28.547

8.  The effects of different high-fat (lard, soybean oil, corn oil or olive oil) diets supplemented with fructo-oligosaccharides on colonic alkaline phosphatase activity in rats.

Authors:  Yukako Okazaki; Tetsuyuki Katayama
Journal:  Eur J Nutr       Date:  2020-03-19       Impact factor: 5.614

9.  Intestinal alkaline phosphatase targets the gut barrier to prevent aging.

Authors:  Florian Kühn; Fatemeh Adiliaghdam; Paul M Cavallaro; Sulaiman R Hamarneh; Amy Tsurumi; Raza S Hoda; Alexander R Munoz; Yashoda Dhole; Juan M Ramirez; Enyu Liu; Robin Vasan; Yang Liu; Ehsan Samarbafzadeh; Rocio A Nunez; Matthew Z Farber; Vanita Chopra; Madhu S Malo; Laurence G Rahme; Richard A Hodin
Journal:  JCI Insight       Date:  2020-03-26

Review 10.  Impact of Modern Drug Therapy on Surgery: Ulcerative Colitis.

Authors:  Florian Kuehn; Richard A Hodin
Journal:  Visc Med       Date:  2018-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.